Rare diseases
Investigational molecules
Locations
Back to Greece696 clinical trials in Thessaloniki, Greece across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
GreeceA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
GreeceEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GreeceA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
GreeceRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GreeceStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
GreeceStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
GreecePhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
GreeceA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
GreecePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
GreeceStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
GreeceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma, multiple myeloma, and advanced malignancies. Research includes innovative treatments for bladder cancer and gastrointestinal tumors.
Investigations emphasize improving survival outcomes and treatment efficacy.
Clinical trials addressing various autoimmune disorders including cutaneous lupus erythematosus, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new biologics and targeted therapies.
Research focuses on developing more effective treatments with improved safety profiles.
Comprehensive studies on Type 1 Diabetes and obesity, investigating novel therapeutic approaches. Trials examine treatments for weight management and glycemic control.
Research aims to improve patient outcomes through innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
